[A multicenter trial of Recormon within the framework of international controlled research].
Tareeva
I E
IE
Nikolaev
A Iu
AIu
Klepikov
P V
PV
Lashutin
S V
SV
Riabov
S I
SI
Shostka
G D
GD
Ermolenko
V M
VM
Rozental'
R L
RL
Vorob'ev
P A
PA
Miagkov
A V
AV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007844:Latvia; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects; D012426:Russia
D011994:Recombinant Proteins; D004921:Erythropoietin
Mnogotsentrovoe ispytanie rekormoa v ramkakh mezhdunarodnogo kontroliruemogo issledovaniia.